Ocugen OCGN
NASDAQ OCGN
$1.36 +0.01 (+0.74%)
At close: Sep 4, 2026 · 4:00 PM EDT

Ocugen (OCGN) Cash from Financing Activities (2014 - 2026)

Ocugen's (OCGN) quarterly Cash from Financing Activities came in at $35.0 million in Q1 2026, up 2909.96% YoY from $1.2 million in Q1 2025, and up 1749100.0% on a QoQ basis from $2000.0 in Q4 2025.

Analysis

Ocugen (OCGN) Cash from Financing Activities (2014 - 2026) Analysis & Trends

Ocugen (OCGN) has 13 years of Cash from Financing Activities data on file, last reported at $35.0 million in Q1 2026.

  • Quarterly Cash from Financing Activities rose 2909.96% year-over-year to $35.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $53.6 million (down 16.0% YoY) and the FY2025 annual result came in at $17.3 million, down 73.28% from the prior year.
  • Cash from Financing Activities improved to $35.0 million in Q1 2026, from $2000.0 in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of $50.1 million in Q1 2022 to a low of -$1.2 million in Q1 2025.
  • A 5-year average of $11.6 million and a median of $962000.0 in 2022 frame the typical range for Cash from Financing Activities.
  • Annual changes were most pronounced in 2024 — Cash from Financing Activities surged 188475.0% — and 2025, when it sank 758.62%.
  • Tracing OCGN's Cash from Financing Activities over 5 years: stood at $8.2 million in 2022, then sank by 99.8% to $16000.0 in 2023, then surged by 188475.0% to $30.2 million in 2024, then sank by 99.99% to $2000.0 in 2025, then jumped by 1749100.0% to $35.0 million in 2026.
  • The last three Cash from Financing Activities figures came in at $35.0 million (Q1 2026), $2000.0 (Q4 2025), and $18.5 million (Q3 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn -426.70 Mn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn -1.22 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 14.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 2.42 Bn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn -6.05 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 36.24 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - -273.15 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 27.18 Mn
10 Ocugen 458.91 Mn 358.81 Mn - 80.37 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 80.37 Mn
Mar 31, 2026 34.98 Mn
Dec 31, 2025 2,000.00
Sep 30, 2025 18.51 Mn
Jun 30, 2025 61,000.00
Mar 31, 2025 -1.25 Mn
Dec 31, 2024 30.17 Mn
Sep 30, 2024 34.79 Mn
Jun 30, 2024 45,000.00
Mar 31, 2024 -145,000.00
Dec 31, 2023 16,000.00
Sep 30, 2023 -35,000.00
Jun 30, 2023 15.40 Mn
Mar 31, 2023 5.50 Mn
Dec 31, 2022 8.18 Mn
Sep 30, 2022 962,000.00
Jun 30, 2022 236,000.00
Mar 31, 2022 50.10 Mn
Dec 31, 2021 605,000.00
Sep 30, 2021 110,000.00